This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.
We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.
Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.
We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.
Terms of use
Privacy Notice
System cookies (required)
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
Google Analytics
This is a web analytics service.
Processing company
Google Ireland Limited
Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
Marketing
Advertisement
Web Analytics
Technologies Used
Cookies
Pixel Tags
Data Attributes
IP address (anonymised)
Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
IP address
Date and time of visit
Usage data
Click path
App updates
Browser information
Device information
JavaScript support
Pages visited
Referrer URL
Downloads
Flash version
Location information
Purchase activity
Widget interactions
Legal Basis
In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
Art. 6 (1) (a) GDPR
Location of Processing
Republic of Serbia
Retention Period
The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
Alphabet Inc.
Facebook Pixel
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
Facebook Ireland Limited
4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
advertising
Marketing
Retargeting
Analyse
Tracking
Technologies Used
Cookies
Data Attributes
Pixel specific data
Http-Header
Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
Facebook user ID
Browser information
Usage data
Geräteinformationen
Non-sensitive custom data
Referrer URL
Pixel ID
Location information
Pixel specific data
User behaviour
Ads viewed
Interactions with advertisement, services, and products
Marketing information
Content viewed
IP address
Legal Basis
In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
Republic of Serbia
Retention Period
The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
Facebook Inc.
ENG
SRB
DEU
Home
About us
Business
Products
Responsibility
Career
Media
Blog
Contact
ENG
SRB
DEU
Home
About us
▾
Company profile
Mission and vision
Management
Representative offices
Production
Our history
Business
▾
R&D
Quality
Stakeholders
Code of Conduct
General conditions of business operations
Products
▾
Report adverse drug reactions
Responsibility
▾
Compliance
Social responsibility
Sustainable development
Career
▾
Corporate culture
Employees
Education of employees
Your career
Media
Blog
Contact
Home
›
Blog
›
Nobody Should Suffer Pain
Nobody Should Suffer Pain
In the 21st century, all patients are entitled to spend their days in peace, without pain, no matter how severe or advanced the disease.
Sometimes the illness brings strong, long-lasting pain that makes you lose sleep and turn your life into suffering. If the pain lasts more than three months, it is called chronic pain.
- The importance of treating pain stems from the fact that pain is the most common reason for seeing a doctor. Chronic pain, which affects about 20 percent of the world's population, occurs in a number of conditions such as rheumatic and neurological diseases, diabetes, AIDS, malignant diseases and more. Most often, chronic pain lasts longer than 6 months, and causes not only physical suffering and damage to the physical health of the patient, but also negatively impacts the mental health and quality of life of the patient – explains Dr. Danijela Stanišić Srdić, clinical pharmacology specialist and Rx sales director at Hemofarm.
People here are used to suffering pain for a long time and chronic pain is still insufficiently treated in our country, although we are actively working on keeping up with modern trends in pain therapy, and clinics and offices for pain therapy have been established throughout Serbia.
- The multidisciplinary Pain Management Office of the UCCS is certainly a bright example, in which a team of top experts works in accordance with the European concept of treatment and where patients with severe, chronic pain find relief. The office is equipped with devices for the most complex intervention procedures, and with new generations of drugs that bring better efficiency in treatment, there is no reason for any patient to suffer pain nowadays – says our collocutor.
In which conditions is pain therapy necessary?
- Whenever there is severe pain present. Pain can be acute or chronic. Acute pain occurs in case of trauma or after surgical procedures. On the other hand, causes of chronic pain can vary. Pain can occur due to spasm of skeletal muscles such as neck or back pain, and we also distinguish between neuropathic pain, pain as an important companion of chronic, inflammatory and degenerative conditions as in the case of osteoarthritis. The treatment of cancer pain requires special attention. Modern pharmacotherapy of pain involves the use of drugs that are characterized by a high degree of efficacy, with an acceptable safety profile – Dr. Stanišić Srdić points out.
One of the most common types of chronic pain is neuropathic pain, which affects about 10 percent of the global population. What causes it?
- There are many pathophysiological mechanisms for its occurrence. Neuropathic pain can be caused by infections such as Herpes Zoster infection, then ischemia in patients with diabetes when painful diabetic polyneuropathy occurs. This pain can also be caused by trauma, damage to the spinal cord, surgery, neurotoxins, radiation, chemotherapy. Patients describe it as severe pain manifesting as burning, tingling, pins and needles – our collocutor explains.
Is neuropathic pain treated with more success these days?
- New generations of medicines significantly facilitate the treatment of neuropathic pain, acting causally and symptomatically. One of the new drugs for the treatment of moderate to severe acute and chronic pain is Tapentadol, which brings a new mechanism of action. Compared to other opioid analgesics, it has fewer gastrointestinal and CNS side effects, therefore, its safety profile is high. Like other medicines, patients must not take Tapentadol on their own, but only according to doctor’s instructions and advice. Nowadays, patients must not suffer pain. They have the right to spend their days in peace, without suffering - emphasizes Dr. Danijela Stanišić Srdić, clinical pharmacology specialist from Hemofarm.